Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Cannara Biotech
company
About
Cannara Biotech is to operate the largest indoor medical cannabis cultivation facility.
- 51 - 100
Highlights
Details
- Last Funding Type
- Post-IPO Debt
- Last Funding Money Raised
- $50M
- Industries
- Biotechnology,Cannabis,Health Care
- Founded date
- Jan 1, 2018
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Cannara Biotech plans to operate the largest indoor medical cannabis cultivation facility in Quebec.The Company will offer a variety of organic cannabis infused medical products and flowers. Cannara Biotech intends to extract oil organically using a supercritical carbon dioxide extractor to ensure clean, potent and pure cannabis oil with a full-spectrum of cannabinoids and terpenes. The company will cultivate inside a recently purchased modern and secure 625,000 square foot facility and will offer its product to both consumers and premium brands throughout Canada and international markets.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$72M
Cannara Biotech has raised a total of
$72M
in funding over 2 rounds. Their latest funding was raised on
Jun 1, 2022 from a Post-IPO Debt round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 1, 2022 | Post-IPO Debt | $50M | 1 |
Bank of Montreal
|
— | Detail |
| Dec 1, 2021 | Post-IPO Debt | $22M | 1 |
CIBC
|
— | Detail |
| Jan 1, 2019 | Series Unknown | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
2
3
Cannara Biotech is funded by 3 investors.
Bank of Montreal
and CIBC
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Bank of Montreal
|
Yes | Post-IPO Debt |
|
CIBC
|
Yes | Post-IPO Debt |
Keiretsu Forum
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
